Dr. Wu Skincare Co., Ltd. (TPEX:6523)

Market Cap	5.54B
Revenue (ttm)	1.22B
Net Income (ttm)	389.13M
Shares Out	45.05M
EPS (ttm)	8.60
PE Ratio	14.30
Forward PE	n/a
Dividend	11.00 (9.05%)
Ex-Dividend Date	Jul 3, 2025

Volume	39,715
Average Volume	101,190
Open	121.50
Previous Close	121.50
Day's Range	121.50 - 123.00
52-Week Range	114.00 - 163.00
Beta	0.13
RSI	52.14
Earnings Date	Aug 10, 2025

About Dr. Wu Skincare

Dr. Wu Skincare Co., Ltd. engages in the research, development, production, wholesale, and retail of cosmetics and skincare products in Taiwan and internationally. The company offers collagen peptide powders, cleansers, masks, toners, serums, hydrating lotions/creams/gels, UV/DD creams, and eye care products, as well as makeup and body products. It also provides products for acne and pores, blackheads, dry skin, signs of aging, dull and spotty skin, sensitive skin, whitening, and emergency care. The company was incorporated in 2003 and is based...

• Industry: Household & Personal Products
• Sector: Consumer Staples
• Founded: 2003
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 6523

Financial Performance

In 2024, Dr. Wu Skincare's revenue was 1.24 billion, an increase of 9.20% compared to the previous year's 1.14 billion. Earnings were 476.25 million, an increase of 12.13%.